Anthropic reports early drug development results with Claude across six partner organizations
Anthropic published preclinical drug development results with Claude on 27 October 2026 from six partners including Bristol Myers Squibb and Enveda.
Summary
Anthropic published on 27 October 2026 early results from drug development work with six partner organizations and its own program. Reported outcomes include a CAR T genetic component about 70% shorter than the standard design, roughly 35,000 antibody designs generated in about a month, antibody variants that bound more than 10 times more tightly, and an 89% cut in human review time for regulatory documents. Anthropic says the work is preclinical and that it plans to expand it.
Tech AI Latest





